Clinical trial
Diagnosis of Disseminated Lyme Borreliosis by Targeted Proteomics
NCT04719962 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diagnosis of Disseminated Lyme Borreliosis by Targeted Proteomics
- Lead sponsor
- University Hospital, Strasbourg, France
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 7, 2021
- Completion date
- July 7, 2022
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.